With 0.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.59 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $2.125 whereas the lowest price it dropped to was $1.835. The 52-week range on NOTV shows that it touched its highest point at $6.48 and its lowest point at $1.15 during that stretch. It currently has a 1-year price target of $5.50. Beta for the stock currently stands at 4.19.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NOTV was down-trending over the past week, with a drop of -3.86%, but this was up by 3.37% over a month. Three-month performance dropped to -8.90% while six-month performance fell -51.34%. The stock lost -51.81% in the past year, while it has gained 18.75% so far this year. A look at the trailing 12-month EPS for NOTV yields -2.69 with Next year EPS estimates of -1.29. For the next quarter, that number is -0.33. This implies an EPS growth rate of 55.92% for this year and 30.17% for next year. EPS is expected to grow by 77.23% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -122.90%.
Float and Shares Shorts:
At present, 34.35 million NOTV shares are outstanding with a float of 29.61 million shares on hand for trading. On 2025-07-31, short shares totaled 2.26 million, which was 656.9999999999999 higher than short shares on 1751241600. In addition to Mr. Robert W. Leasure Jr. as the firm’s President, CEO & Director, Ms. Beth A. Taylor CPA serves as its Senior VP of Finance & CFO.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, NOTV reported revenue of $130683000.0 and operating income of -$5530000.0. The EBITDA in the recently reported quarter was $8974000.0 and diluted EPS was -$0.51.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NOTV since 15 analysts follow the stock currently. There are 8 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 7 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With NOTV analysts setting a high price target of 9.0 and a low target of 2.5, the average target price over the next 12 months is 5.5. Based on these targets, NOTV could surge 350.0% to reach the target high and rise by 25.0% to reach the target low. Reaching the average price target will result in a growth of 175.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$4.42241 being high and -$4.44191 being low. For NOTV, this leads to a yearly average estimate of -$4.435. The surprise factor in the prior quarter was -$0.24. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
